Company: SHPH
Filing Date: 2025-11-26
Form Type: 8-K
Source: 0001493152-25-025082
Chunk: 2

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-11-26
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item
9.01 Financial Statements and Exhibits.

(d)
Exhibits

  Exhibit      Description                                                                                                                                                                  
  No.                                                                                                                                                                                       
  10.1*        Asset Purchase Agreement, dated as of November 20, 2025, by and among Shuttle Pharmaceuticals Holdings, Inc.,1563868 B. C. Ltd., 1542770 BC Ltd., and Zhitian (Andy) Zhang.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  104          Cover                                                                                                                                                                        

*
Schedules and exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally a copy of any
omitted schedule to the Securities and Exchange Commission upon request.

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  SHUTTLE                                                              
  Dated:                                                               
  By:                                 /s/                              
  Name:                               Christopher                      
  Title:                              Interim Chief Executive Officer